When.com Web Search

Search results

1. Results From The WOW.Com Content Network

2. National Defence Academy and Naval Academy Examination

   en.wikipedia.org/wiki/National_Defence_Academy...

   The National Defence Academy and Naval Academy Examination is an entrance examination conducted by the Union Public Service Commission (UPSC) twice a year for admissions into the National Defence Academy (NDA) and Indian Naval Academy (INA). [1] The NDA Exam serves as a gateway for candidates seeking a career in the Indian Army, Navy, and Air ...

3. National Defense Authorization Act for Fiscal Year 2025

   en.wikipedia.org/wiki/National_Defense...

   On May 22, the House Armed Services Committee approved its version of the 2025 National Defense Authorization Act, by a 57–1 vote. [6] As passed by the Committee, the bill included the Pentagon's controversial "Legislative Proposal 480", transferring Air National Guard space units to the Space Force; however, the Committee accepted an amendment proposed by Joe Wilson (R‑SC), watering down ...

4. NDA - Wikipedia

   en.wikipedia.org/wiki/NDA

   New Drug Application, to get a new drug approved in the United States by the Food and Drug Administration; Non-destructive analysis, a way to evaluate a material's properties without destroying it; Non-disclosure agreement, a legal contract regarding confidentiality; Notre Dame Academy, Patna, a girls' Roman Catholic secondary school in Patna ...

5. Marketing authorisation - Wikipedia

   en.wikipedia.org/wiki/Marketing_authorisation

   The application dossier for marketing authorisation is called a New Drug Application (NDA) in the USA or Marketing Authorisation Application (MAA) in the European Union and other countries, or simply registration dossier. This contains data proving that the drug has quality, efficacy and safety properties suitable for the intended use ...

6. NPS Pharmaceuticals Reports Characteristics of Patients Who ...

   www.aol.com/news/2012-10-22-nps-pharmaceuticals...

   The committee's recommendation will be considered by the FDA in its review of the company's NDA. The Prescription Drug User Fee Act (PDUFA) date for completion of the review is December 30, 2012.

7. Iovance Biotherapeutics Pushes FDA Rolling Submission ...

   www.aol.com/iovance-biotherapeutics-pushes-fda...

   Iovance Biotherapeutics Inc (NASDAQ: IOVA) announced that its ongoing rolling Biologics License Application (BLA) submission to the FDA for lifileucel is expected to be completed in the first ...